| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $2.6M | +0.0% |
| R&D Expense | $61.4M | +21.4% |
| SG&A Expense | $30.7M | +23.0% |
| Operating Income | -$92.1M | -26.3% |
| Interest Expense | $4.1M | +93.7% |
| Net Income | -$87.4M | -18.4% |
| EPS (Basic) | -$3.96 | -942.1% |
| EPS (Diluted) | -$3.93 | -934.2% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $77.9M | +4.0% |
| Current Assets | $143.7M | +54.7% |
| Total Assets | $149.7M | +57.5% |
| Current Liabilities | $26.4M | +21.8% |
| Long-term Debt | $40.1M | +63.4% |
| Total Liabilities | $71.2M | +49.4% |
| Stockholders' Equity | $57.4M | +21.1% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$86.5M | -35.8% |
| Capital Expenditures | $196K | — |
| Investing Cash Flow | -$44.4M | -167.2% |
| Financing Cash Flow | $134.2M | +159.1% |
| Free Cash Flow | -$86.7M | — |